Fujifilm India Installs 125 AMULET Innovality Digital Mammography Machines Across India

New Delhi : FUJIFILM India, a leading pioneer in advancing healthcare imaging technologies, has achieved a significant milestone by deploying 125 AMULET Innovality digital mammography machines across India, marking a noteworthy advancement in the field of digital mammography. This achievement underscores the company’s commitment to enhancing the fight against breast cancer and expanding its installation base continually.

According to Globocan data from 2020, breast cancer constituted 13.5% (178,361 cases) of all cancer diagnoses and 10.6% (90,408 cases) of all cancer-related deaths in India. These statistics emphasize the critical importance of early breast cancer detection in improving survival rates.

As reported by IndiaEducationDiary.com, FUJIFILM India believes it has a societal obligation to raise awareness about early breast cancer detection and equip healthcare professionals with cutting-edge technologies to better serve the community. To further this mission, the ‘Together Against Breast Cancer’ conference was held in Goa from September 15th to 17th, 2023.

Koji Wada, Managing Director, FUJIFILM India said, “At FUJIFILM India, our unwavering commitment to women’s health is exemplified by the technologies we bring and the advocacy we do for early diagnosis. The installation of 125 AMULET Innovality digital mammography machines across India are a testament to our dedication to enhance healthcare infrastructure for the early detection of breast cancer. However, I strongly feel that 125 is just a milestone in this journey and we will be expanding our installation base with a very fast pace in the near future. Beyond our advancements in healthcare technology, our ‘Together Against Breast Cancer’ Conference is proudly celebrating its 3rd edition, reinforcing our commitment to raising awareness. We firmly believe that improving access to technology and increasing awareness are pivotal steps toward fostering a healthier India”.

Related Posts

  • Pharma
  • April 26, 2025
  • 149 views
Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Mumbai:  Suven Pharmaceuticals Limited, a contract development and manufacturing organization (CDMO), has announced that it has received final approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers,…

  • Pharma
  • April 26, 2025
  • 115 views
Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

India’s largest diagnostics service provider, Dr Lal PathLabs (DLPL), on Friday reported an 81.4 per cent year-on-year (Y-o-Y) increase in consolidated net profit for the March quarter of financial year…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

250% rally in one year! Multibagger pharma stock jumps despite stock market crash

250% rally in one year! Multibagger pharma stock jumps despite stock market crash